BIOCHEMFUSION ApS: Financial statements 2023
CVR: 32057446
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BIOCHEMFUSION ApS (CVR 32057446) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 823,937 and a net result of DKK 83,203 compared with DKK -12,841 the year before. That is an increase of 15.6% compared with the year before. Equity in the 2023 report amounted to DKK 360,665. The solvency ratio was 68.9%.
- Gross Profit
- DKK 823,937
- Profit/Loss
- DKK 83,203
- Equity
- DKK 360,665
- Total Assets
- DKK 523,755
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 824 t. | 83 t. | 361 t. | - |
| 2022 | - | 713 t. | -13 t. | 277 t. | - |
| 2021 | - | 946 t. | 190 t. | 440 t. | - |
| 2020 | - | 832 t. | 116 t. | 400 t. | - |
| 2019 | - | 869 t. | 452 t. | 734 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BIOCHEMFUSION ApS has published its annual report for 2022. Gross profit came to DKK 712,538, and the net result was DKK -12,841.
About BIOCHEMFUSION ApS
BIOCHEMFUSION ApS is a Danish company of the type Anpartsselskab based in Ølsted, founded in 2009. The company is registered under the industry Anden udgivelse af software. The management consists of Jan Holst Jensen. The company is owned by BIOCHEMFUSION HOLDING ApS. In 2025, the company reported a gross profit of DKK 1,156,041 and a net result of DKK 194,096 compared with DKK -4,593 the year before. Equity in the 2025 report amounted to DKK 475,167.